Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing
Christof C Smith1, Jooho Chung2, Areej El-Jawahri2
1Massachusetts General Brigham Cancer Center, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
Transplantation and Cellular Therapy
|August 13, 2025
Abstract
No abstract available in PubMed .


